Previous 10 | Next 10 |
AcelRx Pharmaceuticals (NASDAQ:ACRX) perks up 3.2% premarket after announcing a merger agreement to acquire privately held, Lowell Therapeutics. Lowell develops Niyad, a regional anticoagulant for the dialysis circuit during continuous renal replacement therapy for acute kidney inju...
AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results AcelRx to expand its pipeline with Niyad™, Lowell's investigational product that has received Breakthrough Designation status from the FDA Lowell provides AcelRx div...
ACM, ACRX, ADN, AMPY, AVPT, AYRO, BCLI, BFLY, CLSN, OTCQB:CVSI, FREY, GMDA, GOED, KALA, MICT, OEG, ONDS, OTLY, PLX, PTN, RAIL, SOHU, TLS, TRVN, TSN, VBLT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
AcelRx to Host Third Quarter 2021 Financial Results Call and Webcast on November 15, 2021 PR Newswire HAYWARD, Calif. , Nov. 10, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it wil...
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the appointment of Meera J. Desai, Ph.D., as a new director and member of the company’s board of directors. Dr. Desai replaces Roshawn Blunt, who retired from the Board ...
DSUVIA 2q21 revenues were below my and market expectations. But management provided further details regarding the Europe out-licensing agreement for DSUVIA and the in-licensing agreements. And Formulary Approvals have picked up substantially also indicating gradually increasing in...
AcelRx Pharmaceuticals to Participate in Two September Investor Conferences PR Newswire HAYWARD, Calif. , Sept. 10, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and comme...
Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery Event PR Newswire HAYWARD, Calif. , Aug. 30, 2021 /PRNewswire/ -- AcelRx Pharmaceutical...
Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery Event PR Newswire HAYWARD, Calif. , Aug. 26, 2021 /PRNewswire/ -- ...
Wall Street Firms Are Bullish On These 5 Cheap Stocks Finding cheap stocks to buy doesn’t have to be complicated. Discovering new trends and opportunities early. Just look at the surging stocks this week like Virpax Pharma ( NASDAQ: VRPX ) and SGOCO Group, Ltd. ( ...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...